Maintenance Notice (3:30 - 10:00 AM December 21, 2024 UTC): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.197 | Notice of Discontinuing the Use of Password-Protected Compressed Files | Product Document Searching Made Easy by 2D Code! | TCI Life Science News December 2024 | [TCIPracticalExample] Reduction of Amide Group Using... | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
Please select the quantity
Xanthine Oxidase Inhibitor - Febuxostat
No.195(March 2024)
Febuxostat (1) is known as an inhibitor of xanthine oxidase. Xanthine oxidase is involved in the conversion of xanthine to uric acid. By inhibiting this enzyme, 1 reduces the production of uric acid.1)
Recently, 1 has been reported to suppress NLR family pyrin domain-containing protein 3 (NLRP3) inflammasome-mediated IL-1β secretion and may be applied in related research studies.2)
References
- 1) Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome
- 2) Febuxostat, a Xanthine Oxidoreductase Inhibitor, Decreases NLRP3-dependent Inflammation in Macrophages by Activating the Purine Salvage Pathway and Restoring Cellular Bioenergetics
The prices are subject to change without notice. Please confirm the newest price by our online catalog before placing an order.
In addition, sales products changes with areas. Please understand that a product is not available when the product details page is not displayed.